Modulation of neurotrophic signaling pathways by polyphenols

Drug Design, Development and Therapy

Volumn 10, Issue , 2015, Pages 23-42

  Moosavi, Fatemeh ^a,b   Hosseini, Razieh ^a,b   Saso, Luciano ^c   Firuzi, Omidreza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY   (Iran)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Flavonoids; Hydroxycinnamic acids; Neurodegeneration; Neuroprotective; Trk

Indexed keywords

AURAPTENE; BAICALEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CAFFEIC ACID PHENETHYL ESTER; CARNOSIC ACID; CHRYSIN; COUMARIC ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DAIDZEIN; EPIGALLOCATECHIN GALLATE; FISETIN; GENISTEIN; HEME OXYGENASE 1; ISORHAMNETIN; LIQUIRITIN; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; NOBILETIN; OROXYLIN A; POLYPHENOL; PROTEIN KINASE B; QUERCETIN; SCUTELLARIN; SYNAPSIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR NRF2; UNINDEXED DRUG; ANTIOXIDANT; NEUROPROTECTIVE AGENT;

ANTIOXIDANT ACTIVITY; APOPTOSIS; BINDING AFFINITY; BRAIN FUNCTION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CURCUMA LONGA; CYTOSKELETON; CYTOTOXICITY; DIMERIZATION; DRUG ACTIVITY; HUMAN; NERVE FIBER GROWTH; NEUROMODULATION; NEUROPROTECTION; PRESYNAPTIC MEMBRANE; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SPATIAL LEARNING; ANIMAL; DRUG EFFECTS; METABOLISM; NERVE CELL; NEURODEGENERATIVE DISEASES; PATHOPHYSIOLOGY; PC12 CELL LINE; RAT;

ANIMALS; ANTIOXIDANTS; CELL SURVIVAL; HUMANS; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; PC12 CELLS; POLYPHENOLS; RATS; SIGNAL TRANSDUCTION;

EID: 84951801634     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S96936     Document Type: Review

References (206)

1. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79(5):727-747.
2. Link A, Balaguer F, Goel A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol. 2010;80(12):1771-1792.
3. Weng CJ, Yen GC. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev. 2012;38(1):76-87.
4. Darvesh AS, Bishayee A. Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer. Nutr Cancer. 2013;65(3):329-344.
5. Annuzzi G, Bozzetto L, Costabile G, et al. Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized controlled trial. Am J Clin Nutr. 2014;99(3):463-471.
6. Shay J, Elbaz HA, Lee I, Zielske SP, Malek MH, Huttemann M. Molecular mechanisms and therapeutic effects of (-)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration. Oxid Med Cell Longev. 2015;2015:181260.
7. Dai J, Mumper RJ. Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules. 2010;15(10):7313-7352.
8. Pocernich CB, Lange ML, Sultana R, Butterfield DA. Nutritional approaches to modulate oxidative stress in Alzheimer's disease. Curr Alzheimer Res. 2011;8(5):452-469.
9. Vauzour D, Vafeiadou K, Rodriguez-Mateos A, Rendeiro C, Spencer JP. The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr. 2008;3(3-4):115-126.
10. Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr. 2005;45(4):287-306.
11. Bhullar KS, Rupasinghe H. Polyphenols: multipotent therapeutic agents in neurodegenerative diseases. Oxid Med Cell Longev. 2013;2013.
12. Ebrahimi A, Schluesener H. Natural polyphenols against neurodegenerative disorders: potentials and pitfalls. Ageing Res Rev. 2012;11(2):329-345.
13. Li H, Zhang Y, Cao L, et al. Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy. Drug Des Devel Ther. 2014;8:2121-2128.
14. Larson AJ, Symons JD, Jalili T. Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms. Adv Nutr. 2012;3(1):39-46.
15. Quiñones M, Miguel M, Aleixandre A. Beneficial effects of polyphenols on cardiovascular disease. Pharmacol Res. 2013;68(1):125-131.
16. Fresco P, Borges F, Marques M, Diniz C. The anticancer properties of dietary polyphenols and its relation with apoptosis. Curr Pharm Des. 2010;16(1):114-134.
17. Nishiumi S, Miyamoto S, Kawabata K, et al. Dietary flavonoids as cancer-preventive and therapeutic biofactors. Front Biosci. 2010;3: 1332-1362.
18. Martin MA, Goya L, Ramos S. Potential for preventive effects of cocoa and cocoa polyphenols in cancer. Food Chem Toxicol. 2013;56:336-351.
19. Conte E, Fagone E, Fruciano M, Gili E, Iemmolo M, Vancheri C. Anti-inflammatory and antifibrotic effects of resveratrol in the lung. Histol Histopathol. 2014;30(5):523-529.
20. Gonzalez R, Ballester I, Lopez-Posadas R, et al. Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr. 2011;51(4):331-362.
21. Babu PVA, Liu D, Gilbert ER. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem. 2013;24(11):1777-1789.
22. Assini JM, Mulvihill EE, Huff MW. Citrus flavonoids and lipid metabolism. Curr Opin Lipidol. 2013;24(1):34-40.
23. Yao Z, Zhang L, Ji G. Efficacy of polyphenolic ingredients of Chinese herbs in treating dyslipidemia of metabolic syndromes. Eur J Integr Med. 2014;12(3):135-146.
24. Islam B, Sharma C, Adem A, Aburawi E, Ojha S. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking. Drug Des Devel Ther. 2015;9:4943-4951.
25. Chirumbolo S. Dietary assumption of plant polyphenols and prevention of allergy. Curr Pharm Des. 2014;20(6):811-839.
26. Cuevas A, Saavedra N, Salazar LA, Abdalla DS. Modulation of immune function by polyphenols: possible contribution of epigenetic factors. Nutrients. 2013;5(7):2314-2332.
27. Cimino S, Sortino G, Favilla V, et al. Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxid Med Cell Longev. 2012;2012.
28. Jin H, Leng Q, Li C. Dietary flavonoid for preventing colorectal neoplasms. Cochrane Libr. 2012;8:CD009350.
29. Zand H. Chemopreventive and chemosensitization potential of flavonoids in acute lymphoblastic leukemia. J Pediatr Biochem. 2012;2(1):15-21.
30. Querfurth HW, LaFerla FM. Alzheimer's disease. New Engl J Med. 2010;362(4):329-344.
31. Citron M. Alzheimer's disease: strategies for disease modification. Nat Rev Drug Discov. 2010;9(5):387-398.
32. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. Alzheimer's disease: clinical trials and drug development. Lancet Neurol. 2010;9(7):702-716.
33. Shay J, Elbaz HA, Lee I, Zielske SP, Malek MH, Hüttemann M. Molecular mechanisms and therapeutic effects of (−)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration. Oxid Med Cell Longev. 2015;2015.
34. Albarracin SL, Stab B, Casas Z, et al. Effects of natural antioxidants in neurodegenerative disease. Nutr Neurosci. 2012;15(1):1-9.
35. Krikorian R, Boespflug EL, Fleck DE, et al. Concord grape juice supplementation and neurocognitive function in human aging. J Agric Food Chem. 2012;60(23):5736-5742.
36. Witte AV, Kerti L, Margulies DS, Flöel A. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci. 2014;34(23): 7862-7870.
37. Kesse-Guyot E, Fezeu L, Andreeva VA, et al. Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later. J Nutr. 2012;142(1):76-83.
38. Letenneur L, Proust-Lima C, Le Gouge A, Dartigues J-F, Barberger-Gateau P. Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol. 2007;165(12):1364-1371.
39. Cimrová B, Budáč S, Melicherová U, Jergelová M, Jagla F. Electrophysiological evidence of the effect of natural polyphenols upon the human higher brain functions. Neuro Endocrinol Lett. 2011;32(4):464-468.
40. Torre R, Sola S, Pons M, et al. Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Mol Nutr Food Res. 2014;58(2):278-288.
41. Gundimeda U, McNeill TH, Schiffman JE, Hinton DR, Gopalakrishna R. Green tea polyphenols potentiate the action of nerve growth factor to induce neuritogenesis: possible role of reactive oxygen species. J Neurosci Res. 2010;88(16):3644-3655.
42. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis. 1998;19(10):1771-1776.
43. El Mohsen MMA, Kuhnle G, Rechner AR, et al. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med. 2002;33(12):1693-1702.
44. Rossi L, Mazzitelli S, Arciello M, Capo C, Rotilio G. Benefits from dietary polyphenols for brain aging and Alzheimer's disease. Neurochem Res. 2008;33(12):2390-2400.
45. Vingtdeux V, Giliberto L, Zhao H, et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-β peptide metabolism. J Biol Chem. 2010;285(12):9100-9113.
46. Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med. 2004;36(5):592-604.
47. Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem. 2003;85(1):180-192.
48. Firuzi O, Lacanna A, Petrucci R, Marrosu G, Saso L. Evaluation of the antioxidant activity of flavonoids by "ferric reducing antioxidant power" assay and cyclic voltammetry. Biochim Biophys Acta. 2005;1721(1-3):174-184.
49. Firuzi O, Mladěnka P, Petrucci R, Marrosu G, Saso L. Hypochlorite scavenging activity of flavonoids. J Pharm Pharmacol. 2004;56(6): 801-807.
50. Dueñas M, González-Manzano S, González-Paramás A, Santos-Buelga C. Antioxidant evaluation of O-methylated metabolites of catechin, epicatechin and quercetin. J Pharm Biomed Anal. 2010;51(2):443-449.
51. Lemmens KJ, van de Wier B, Vaes N, et al. The flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside is able to protect endothelial cells by a direct antioxidant effect. Toxicol in Vitro. 2014;28(4):538-543.
52. Martín MÁ, Fernández-Millán E, Ramos S, Bravo L, Goya L. Cocoa flavonoid epicatechin protects pancreatic beta cell viability and function against oxidative stress. Mol Nutr Food Res. 2014;58(3):447-456.
53. Garrido J, Gaspar A, Garrido EM, et al. Alkyl esters of hydroxycinnamic acids with improved antioxidant activity and lipophilicity protect PC12 cells against oxidative stress. Biochimie. 2012;94(4):961-967.
54. Gaspar A, Martins M, Silva P, et al. Dietary phenolic acids and derivatives. Evaluation of the antioxidant activity of sinapic acid and its alkyl esters. J Agric Food Chem. 2010;58(21):11273-11280.
55. Chen J, Chua K-W, Chua CC, et al. Antioxidant activity of 7, 8-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity. Neurosci Lett. 2011;499(3):181-185.
56. Vauzour D. Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev. 2012;2012:914273.
57. Gutierrez-Merino C, Lopez-Sanchez C, Lagoa R, Samhan-Arias AK, Bueno C, Garcia-Martinez V. Neuroprotective actions of flavonoids. Curr Med Chem. 2011;18(8):1195-1212.
58. Hwang S-L, Shih P-H, Yen G-C. Neuroprotective effects of citrus flavonoids. J Agric Food Chem. 2012;60(4):877-885.
59. Venkatesan R, Ji E, Kim SY. Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review. Biomed Res Int. 2015;2015:814068.
60. Silva T, Bravo J, Summavielle T, et al. Biology-oriented development of novel lipophilic antioxidants with neuroprotective activity. RSC Adv. 2015;5(21):15800-15811.
61. Darvesh AS, Carroll RT, Bishayee A, Geldenhuys WJ, Van der Schyf CJ. Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother. 2010;10(5):729-745.
62. Firuzi O, Miri R, Tavakkoli M, Saso L. Antioxidant therapy: current status and future prospects. Curr Med Chem. 2011;18(25):3871-3888.
63. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000;407(6805):802-809.
64. Lin C-W, Wu M-J, Liu IY-C, Su J-D, Yen J-H. Neurotrophic and cytoprotective action of luteolin in PC12 cells through ERK-dependent induction of Nrf2-driven HO-1 expression. J Agric Food Chem. 2010;58(7):4477-4486.
65. Liao K-K, Wu M-J, Chen P-Y, et al. Curcuminoids promote neurite outgrowth in PC12 cells through MAPK/ERK-and PKC-dependent pathways. J Agric Food Chem. 2011;60(1):433-443.
66. Reznichenko L, Amit T, Youdim M, Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J Neurochem. 2005;93(5):1157-1167.
67. dos Santos NAG, Martins NM, de Barros Silva R, Ferreira RS, Sisti FM, dos Santos AC. Caffeic acid phenethyl ester (CAPE) protects PC12 cells from MPP+ toxicity by inducing the expression of neuron-typical proteins. NeuroToxicology. 2014;45:131-138.
68. Lai H-C, Wu M-J, Chen P-Y, et al. Neurotrophic effect of citrus 5-hydroxy-3, 6, 7, 8, 3′, 4′-hexamethoxyflavone: promotion of neurite outgrowth via cAMP/PKA/CREB pathway in PC12 cells. PLoS One. 2011;6(11):e28280.
69. Yang S-H, Liao C-C, Chen Y, Syu J-P, Jeng C-J, Wang S-M. Daidzein induces neuritogenesis in DRG neuronal cultures. J Biomed Sci. 2012;19:80.
70. Tsai T, Klausmeyer A, Conrad R, et al. 7, 8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways. Mol Cell Neurosci. 2013;56:18-28.
71. Tangsaengvit N, Kitphati W, Tadtong S, Bunyapraphatsara N, Nukoolkarn V. Neurite outgrowth and neuroprotective effects of quercetin from Caesalpinia mimosoides Lamk. on cultured P19-derived neurons. Evid Based Complement Alternat Med. 2013;2013:838051.
72. Yabe T, Hirahara H, Harada N, et al. Ferulic acid induces neural progenitor cell proliferation in vitro and in vivo. Neuroscience. 2010;165(2):515-524.
73. Tang BL. Protein trafficking mechanisms associated with neurite outgrowth and polarized sorting in neurons. J Neurochem. 2001;79(5):923-930.
74. Das KP, Freudenrich TM, Mundy WR. Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures. Neurotoxicol Teratol. 2004;26(3):397-406.
75. Nakajima K-I, Niisato N, Marunaka Y. Genistein enhances the NGF-induced neurite outgrowth. Biomed Res. 2011;32(5):351-356.
76. Chen Z-A, Wang J-L, Liu R-T, et al. Liquiritin potentiate neurite outgrowth induced by nerve growth factor in PC12 cells. Cytotechnology. 2009;60(1-3):125-132.
77. Xu SL, Choi RC, Zhu KY, et al. Isorhamnetin, a flavonol aglycone from Ginkgo biloba L., induces neuronal differentiation of cultured PC12 cells: potentiating the effect of nerve growth factor. Evid Based Complement Alternat Med. 2012;2012:278273.
78. Li Y, Chen X, Satake M, Oshima Y, Ohizumi Y. Acetylated flavonoid glycosides potentiating NGF action from scoparia dulcis. J Nat Prod. 2004;67(4):725-727.
79. Zhang F, Wang Y-Y, Liu H, et al. Resveratrol produces neurotrophic effects on cultured dopaminergic neurons through prompting astroglial BDNF and GDNF release. Evid Based Complement Alternat Med. 2012;2012:937605.
80. Wang P, Jeng C-J, Chien C-L, Wang S-M. Signaling mechanisms of daidzein-induced axonal outgrowth in hippocampal neurons. Biochem Biophys Res Commun. 2008;366(2):393-400.
81. Agrawal R, Noble E, Tyagi E, Zhuang Y, Ying Z, Gomez-Pinilla F. Flavonoid derivative 7, 8-DHF attenuates TBI pathology via TrkB activation. Biochim Biophys Acta. 2015;1852(5):862-872.
82. Zhao J, Cheng YY, Fan W, et al. Botanical drug puerarin coordinates with nerve growth factor in the regulation of neuronal survival and neuritogenesis via activating ERK1/2 and PI3K/Akt signaling pathways in the neurite extension process. CNS Neurosci Ther. 2015;21(1):61-70.
83. Ta LE, Espeset L, Podratz J, Windebank AJ. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology. 2006;27(6):992-1002.
84. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249(1):9-17.
85. Klein R, Brown D, Turnley AM. Phenoxodiol protects against Cisplatin induced neurite toxicity in a PC-12 cell model. BMC Neurosci. 2007;8(1):61.
86. Kamsteeg M, Rutherford T, Sapi E, et al. Phenoxodiol-an isoflavone analog-induces apoptosis in chemoresistant ovarian cancer cells. Oncogene. 2003;22(17):2611-2620.
87. Dikshit P, Goswami A, Mishra A, Catterjee M, Jana NR. Curcumin induces stress response, neurite outgrowth and prevent NF-κB activation by inhibiting the proteasome function. Neurotox Res. 2006;9(1):29-37.
88. Levy YS, Gilgun-Sherki Y, Melamed E, Offen D. Therapeutic potential of neurotrophic factors in neurodegenerative diseases. Bio Drugs. 2005;19(2):97-127.
89. Hyman C, Hofer M, Barde YA, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 1991;350(6315):230-232.
90. Maisonpierre PC, Belluscio L, Friedman B, et al. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron. 1990;5(4):501-509.
91. Schindowski K, Belarbi K, Buee L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav. 2008;7(s1):43-56.
92. Longo FM, Massa SM. Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease. Nat Rev Drug Discov. 2013;12(7):507-525.
93. Nagahara AH, Tuszynski MH. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov. 2011;10(3):209-219.
94. Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther. 2013;138(2):155-175.
95. Huang EJ, Reichardt LF. Trk receptors: Roles in neuronal signal transduction. Annu Rev Biochem. 2012;722003:609-642.
96. Webster NJ, Pirrung MC. Small molecule activators of the Trk receptors for neuroprotection. BMC Neuroscience. 2008;9 (Suppl 2):S1.
97. Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003;4(4):299-309.
98. Ultsch MH, Wiesmann C, Simmons LC, et al. Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC. J Mol Biol. 1999;290(1):149-159.
99. Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72(1):609-642.
100. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 2000;10(3):381-391.
101. Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol. 2001;11(3):272-280.
102. Jang S-W, Liu X, Yepes M, et al. A selective TrkB agonist with potent neurotrophic activities by 7, 8-dihydroxyflavone. Proc Natl Acad Sci U S A. 2010;107(6):2687-2692.
103. Gupta VK, You Y, Li JC, Klistorner A, Graham SL. Protective effects of 7, 8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress. J Mol Neurosci. 2013;49(1):96-104.
104. Yu Q, Chang Q, Liu X, et al. Protection of spiral ganglion neurons from degeneration using small-molecule TrkB receptor agonists. J Neurosci. 2013;33(32):13042-13052.
105. Al-Gayyar M, Matragoon S, Pillai B, Ali T, Abdelsaid M, El-Remessy A. Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor proNGF expression in a rat model of diabetes. Diabetologia. 2011;54(3):669-680.
106. Chai L, Guo H, Li H, et al. Scutellarin and caffeic acid ester fraction, active components of Dengzhanxixin injection, upregulate neurotrophins synthesis and release in hypoxia/reoxygenation rat astrocytes. J Ethnopharmacol. 2013;150(1):100-107.
107. Xu SL, Bi CW, Choi RC, et al. Flavonoids induce the synthesis and secretion of neurotrophic factors in cultured rat astrocytes: a signaling response mediated by estrogen receptor. Evid Based Complement Alternat Med. 2013;2013:127075.
108. Sohrabji F, Miranda R, Toran-Allerand CD. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci U S A. 1995;92(24):11110-11114.
109. Park SJ, Kim DH, Kim JM, et al. Mismatch between changes in baicalein-induced memory-related biochemical parameters and behavioral consequences in mouse. Brain Res. 2010;1355:141-150.
110. Cho N, Lee KY, Huh J, et al. Cognitive-enhancing effects of Rhus verniciflua bark extract and its active flavonoids with neuroprotective and anti-inflammatory activities. Food Chem Toxicol. 2013;58:355-361.
111. Souza LC, Antunes MS, Borges Filho C, et al. Flavonoid Chrysin prevents age-related cognitive decline via attenuation of oxidative stress and modulation of BDNF levels in aged mouse brain. Pharmacol Biochem Behav. 2015;134:22-30.
112. Pan M, Han H, Zhong C, Geng Q. Effects of genistein and daidzein on hippocampus neuronal cell proliferation and BDNF expression in H19-7 neural cell line. J Nutr Health Aging. 2012;16(4):389-394.
113. Okuyama S, Shimada N, Kaji M, et al. Heptamethoxyflavone, a citrus flavonoid, enhances brain-derived neurotrophic factor production and neurogenesis in the hippocampus following cerebral global ischemia in mice. Neurosci Lett. 2012;528(2):190-195.
114. Jeon SJ, Bak H, Seo J, et al. Oroxylin A induces BDNF expression on cortical neurons through adenosine A2A receptor stimulation: a possible role in neuroprotection. Biomol Ther. 2012;20(1):27.
115. Li R, Liang T, Xu L, Zheng N, Zhang K, Duan X. Puerarin attenuates neuronal degeneration in the substantia nigra of 6-OHDA-lesioned rats through regulating BDNF expression and activating the Nrf2/ARE signaling pathway. Brain Res. 2013;1523:1-9.
116. Liu P, Zou D, Yi L, et al. Quercetin ameliorates hypobaric hypoxia-induced memory impairment through mitochondrial and neuron function adaptation via the PGC-1α pathway. Restor Neurol Neurosci. 2015;33(2):143-157.
117. Kurauchi Y, Hisatsune A, Isohama Y, Mishima S, Katsuki H. Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase-1 and brain-derived neurotrophic factor. Br J Pharmacol. 2012;166(3):1151-1168.
118. Hoppe JB, Coradini K, Frozza RL, et al. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway. Neurobiol Learn Mem. 2013;106:134-144.
119. Zhang F, Lu Y-F, Wu Q, Liu J, Shi J-S. Resveratrol promotes neurotrophic factor release from astroglia. Exp Biol Med. 2012;237(8):943-948.
120. Rahvar M, Nikseresht M, Shafiee SM, et al. Effect of oral resveratrol on the BDNF gene expression in the hippocampus of the rat brain. Neurochem Res. 2011;36(5):761-765.
121. Yuan H, Zhang J, Liu H, Li Z. The protective effects of resveratrol on Schwann cells with toxicity induced by ethanol in vitro. Neurochem Int. 2013;63(3):146-153.
122. Moriya J, Chen R, Yamakawa J-I, Sasaki K, Ishigaki Y, Takahashi T. Resveratrol improves hippocampal atrophy in chronic fatigue mice by enhancing neurogenesis and inhibiting apoptosis of granular cells. Biol Pharm Bull. 2011;34(3):354-359.
123. Liu R, Gao M, Qiang G-F, et al. The anti-amnesic effects of luteolin against amyloid β 25-35 peptide-induced toxicity in mice involve the protection of neurovascular unit. Neuroscience. 2009;162(4):1232-1243.
124. Lee YW, Kim DH, Jeon SJ, et al. Neuroprotective effects of salvianolic acid B on an Aβ 25-35 peptide-induced mouse model of Alzheimer's disease. Eur J Pharmacol. 2013;704(1):70-77.
125. Donato F, de Gomes MG, Goes ATR, et al. Hesperidin exerts antidepressant-like effects in acute and chronic treatments in mice: Possible role of L-arginine-NO-cGMP pathway and BDNF levels. Brain Res Bull. 2014;104:19-26.
126. Wang Z, Gu J, Wang X, et al. Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK. Pharmacol Biochem Behav. 2013;112:104-110.
127. Su GY, Yang JY, Wang F, et al. Antidepressant-like effects of Xiaochaihutang in a rat model of chronic unpredictable mild stress. J Ethnopharmacol. 2014;152(1):217-226.
128. Lv Q-Q, Wu W-J, Guo X-L, et al. Antidepressant activity of astilbin: involvement of monoaminergic neurotransmitters and BDNF signal pathway. Biol Pharm Bull. 2014;37(6):987-995.
129. Xiong Z, Jiang B, Wu P-F, et al. Antidepressant effects of a plant-derived flavonoid baicalein involving extracellular signal-regulated kinases cascade. Biol Pharm Bull. 2011;34(2):253-259.
130. Liu D, Xie K, Yang X, et al. Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats. Behav Brain Res. 2014;264:9-16.
131. Jin X, Liu P, Yang F, Zhang Y-H, Miao D. Rosmarinic acid ameliorates depressive-like behaviors in a rat model of CUS and up-regulates BDNF levels in the hippocampus and hippocampal-derived astrocytes. Neurochem Res. 2013;38(9):1828-1837.
132. Hetman M, Gozdz A. Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem. 2004;271(11):2050-2055.
133. Hetman M, Xia Z. Signaling pathways mediating anti-apoptotic action of neurotrophins. Acta Neurobiol Exp. 2000;60(4):531-546.
134. Satoh Y, Kobayashi Y, Takeuchi A, Pagès G, Pouysségur J, Kazama T. Deletion of ERK1 and ERK2 in the CNS causes cortical abnormalities and neonatal lethality: Erk1 deficiency enhances the impairment of neurogenesis in Erk2-deficient mice. J Neurosci. 2011;31(3):1149-1155.
135. Parmar MS, Jaumotte JD, Wyrostek SL, Zigmond MJ, Cavanaugh JE. The role of ERK1, 2, and 5 in dopamine neuron survival during aging. Neurobiol Aging. 2014;35(3):669-679.
136. Li Z, Theus MH, Wei L. Role of ERK 1/2 signaling in neuronal differentiation of cultured embryonic stem cells. Dev Growth Differ. 2006;48(8):513-523.
137. Li Q, Chen M, Liu H, Yang L, Yang T, He G. The dual role of ERK signaling in the apoptosis of neurons. Front Biosci. 2013;19:1411-1417.
138. Munshi A, Ramesh R. Mitogen-activated protein kinases and their role in radiation response. Genes Cancer. 2013;4(9-10):401-408.
139. Moustafa K, AbuQamar S, Jarrar M, Al-Rajab AJ, Trémouillaux-Guiller J. MAPK cascades and major abiotic stresses. Plant Cell Rep. 2014;33(8):1217-1225.
140. Komis G, Illés P, Beck M, Šamaj J. Microtubules and mitogen-activated protein kinase signalling. Curr Opin Plant Biol. 2011;14(6): 650-657.
141. Yang Y, Bian G, Lu Q. Neuroprotection and neurotrophism effects of liquiritin on primary cultured hippocampal cells. J Chin Mater Med. 2008;33(8):931-935.
142. Wang Z, Zhang X, Wang H, Qi L, Lou Y. Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway. Neuroscience. 2007;145(3):911-922.
143. Moghbelinejad S, Nassiri-Asl M, Farivar TN, et al. Rutin activates the MAPK pathway and BDNF gene expression on beta-amyloid induced neurotoxicity in rats. Toxicol Lett. 2014;224(1):108-113.
144. Lin L-F, Chiu S-P, Wu M-J, Chen P-Y, Yen J-H. Luteolin induces microRNA-132 expression and modulates neurite outgrowth in PC12 cells. PloS One. 2012;7(8):e43304.
145. Kano Y, Horie N, Doi S, et al. Artepillin C derived from propolis induces neurite outgrowth in PC12m3 cells via ERK and p38 MAPK pathways. Neurochem Res. 2008;33(9):1795-1803.
146. Sagara Y, Vanhnasy J, Maher P. Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation. J Neurochem. 2004;90(5):1144-1155.
147. Zhang Z, Cai L, Zhou X, et al. Methyl 3, 4-dihydroxybenzoate promote rat cortical neurons survival and neurite outgrowth through the adenosine A2a receptor/PI3K/Akt signaling pathway. NeuroReport. 2015;26(6):367-373.
148. Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron. 2002;35(4):605-623.
149. Boss V, Roback JD, Young AN, et al. Nerve growth factor, but not epidermal growth factor, increases Fra-2 expression and alters Fra-2/JunD binding to AP-1 and CREB binding elements in pheochromocytoma (PC12) cells. J Neurosci. 2001;21(1):18-26.
150. Mantamadiotis T, Lemberger T, Bleckmann SC, et al. Disruption of CREB function in brain leads to neurodegeneration. Nat Genet. 2002;31(1):47-54.
151. Furukawa Y, Watanabe S, Okuyama S, Nakajima M. Neurotrophic effect of Citrus auraptene: neuritogenic activity in PC12 cells. Int J Mol Sci. 2012;13(5):5338-5347.
152. Nagase H, Omae N, Omori A, et al. Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities. Biochem Biophys Res Commun. 2005;337(4):1330-1336.
153. Hwang S-L, Lin J-A, Shih P-H, Yeh C-T, Yen G-C. Pro-cellular survival and neuroprotection of citrus flavonoid: the actions of hesperetin in PC12 cells. Food Funct. 2012;3(10):1082-1090.
154. Li Q, Zhao H, Zhang Z, et al. Long-term administration of green tea catechins prevents age-related spatial learning and memory decline in C57BL/6 J mice by regulating hippocampal cyclic amp-response element binding protein signaling cascade. Neuroscience. 2009;159(4):1208-1215.
155. Oh SB, Park HR, Jang YJ, Choi SY, Son TG, Lee J. Baicalein attenuates impaired hippocampal neurogenesis and the neurocognitive deficits induced by γ-ray radiation. Br J Pharmacol. 2013;168(2):421-431.
156. Lee B, Sur B, Shim I, Lee H, Hahm D-H. Baicalin improves chronic corticosterone-induced learning and memory deficits via the enhancement of impaired hippocampal brain-derived neurotrophic factor and cAMP response element-binding protein expression in the rat. J Nat Med. 2014;68(1):132-143.
157. Zhao L, Wang J-L, Liu R, Li X-X, Li J-F, Zhang L. Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer's disease mouse model. Molecules. 2013;18(8):9949-9965.
158. Liu R, Li J-Z, Song J-K, et al. Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits. Neurobiol Aging. 2014;35(6):1275-1285.
159. Jin CH, Shin EJ, Park JB, et al. Fustin flavonoid attenuates β-amyloid (1-42)-induced learning impairment. J Neurosci Res. 2009;87(16):3658-3670.
160. Basli A, Soulet S, Chaher N, et al. Wine polyphenols: potential agents in neuroprotection. Oxid Med Cell Longev. 2012;2012.
161. Saso L, Firuzi O. Pharmacological applications of antioxidants: lights and shadows. Curr Drug Targets. 2014;15(13):1177-1199.
162. Amara F, Berbenni M, Fragni M, et al. Neuroprotection by cocktails of dietary antioxidants under conditions of nerve growth factor deprivation. Oxid Med Cell Longev. 2015;2015:217258.
163. Panickar KS, Anderson RA. Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia. Int J Mol Sci. 2011;12(11):8181-8207.
164. Razzaghi-Asl N, Garrido J, Khazraei H, Borges F, Firuzi O. Antioxidant properties of hydroxycinnamic acids: A review of structure-activity relationships. Curr Med Chem. 2013;20(36):4436-4450.
165. Weinreb O, Amit T, Youdim MB. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate. Free Radic Biol Med. 2007;43(4):546-556.
166. Harikumar KB, Aggarwal BB. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle. 2008;7(8):1020-1035.
167. Campos-Esparza MR, Sanchez-Gomez MV, Matute C. Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols. Cell Calcium. 2009;45(4):358-368.
168. Selkoe DJ. Clearing the brain's amyloid cobwebs. Neuron. 2001;32(2):177-180.
169. Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357-367.
170. Ushikubo H, Watanabe S, Tanimoto Y, et al. 3, 3′, 4′, 5, 5′-Pentahydroxyflavone is a potent inhibitor of amyloid β fibril formation. Neurosci Lett. 2012;513(1):51-56.
171. Hong S-Y, Jeong W-S, Jun M. Protective effects of the key compounds isolated from Corni fructus against β-amyloid-induced neurotoxicity in PC12 cells. Molecules. 2012;17(9):10831-10845.
172. Heo HJ, Lee CY. Epicatechin and catechin in cocoa inhibit amyloid β protein induced apoptosis. J Agric Food Chem. 2005;53(5):1445-1448.
173. Meng P, Yoshida H, Tanji K, et al. Carnosic acid attenuates apoptosis induced by amyloid-1-42 or 1-43 in SH-SY5Y human neuroblastoma cells. Neurosci Res. 2015;94:1-9.
174. Mu X, He G, Cheng Y, Li X, Xu B, Du G. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacol Biochem Behav. 2009;92(4):642-648.
175. Tavakkoli M, Miri R, Jassbi AR, et al. Carthamus, Salvia and Stachys species protect neuronal cells against oxidative stress-induced apoptosis. Pharm Biol. 2014;52(12):1550-1557.
176. Sajad M, Zargan J, Zargar MA, et al. Quercetin prevents protein nitration and glycolytic block of proliferation in hydrogen peroxide insulted cultured neuronal precursor cells (NPCs): Implications on CNS regeneration. Neurotoxicology. 2013;36:24-33.
177. Liu B, Zhang H, Xu C, et al. Neuroprotective effects of icariin on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons. Brain Res. 2011;1375:59-67.
178. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89-116.
179. Chung SW, Liu X, Macias AA, Baron RM, Perrella MA. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest. 2008;118(1):239.
180. Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev. 2006;38(4):769-789.
181. Zhang M, An C, Gao Y, Leak RK, Chen J, Zhang F. Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog Neurobiol. 2013;100:30-47.
182. Cho H-Y, Jedlicka AE, Reddy SP, et al. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol. 2002;26(2):175-182.
183. Romeo L, Intrieri M, D'Agata V, et al. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. J Am Coll Nutr. 2009;28(sup4):492S-499S.
184. Kosaka K, Mimura J, Itoh K, et al. Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12h cells. J Biochem. 2010;147(1):73-81.
185. Russell JM. Sodium-potassium-chloride cotransport. Physiol Rev. 2000;80(1):211-276.
186. Nakajima K-I, Miyazaki H, Niisato N, Marunaka Y. Essential role of NKCC1 in NGF-induced neurite outgrowth. Biochem Biophys Res Commun. 2007;359(3):604-610.
187. Nakajima K-I, Niisato N, Marunaka Y. Quercetin stimulates NGF-induced neurite outgrowth in PC12 cells via activation of Na+/K+/2Cl-cotransporter. Cell Physiol Biochem. 2011;28(1):147-156.
188. Diógenes MJ, Fernandes CC, Sebastiao AM, Ribeiro JA. Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices. J Neurosci. 2004;24(12):2905-2913.
189. Tebano M, Martire A, Potenza R, et al. Adenosine A2A receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus. J Neurochem. 2008;104(1):279-286.
190. Wiese S, Jablonka S, Holtmann B, et al. Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB. Proc Natl Acad Sci U S A. 2007;104(43):17210-17215.
191. Cheng H-C, Shih H-M, Chern Y. Essential role of cAMP-response element-binding protein activation by A2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blockage of the MAPK cascade. J Biol Chem. 2002;277(37):33930-33942.
192. Flajolet M, Wang Z, Futter M, et al. FGF acts as a co-transmitter through adenosine A2A receptor to regulate synaptic plasticity. Nat Neurosci. 2008;11(12):1402-1409.
193. Palazzolo G, Horvath P, Zenobi-Wong M. The flavonoid isoquercitrin promotes neurite elongation by reducing RhoA activity. PLoS One. 2012;7(11):e49979.
194. Bora-Tatar G, Erdem-Yurter H. Investigations of curcumin and resveratrol on neurite outgrowth: perspectives on spinal muscular atrophy. Biomed Res Int. 2014;2014:709108.
195. Dasgupta B, Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A. 2007;104(17):7217-7222.
196. Li M, Tsang KS, Choi ST, Li K, Shaw PC, Lau KF. Neuronal differentiation of C17. 2 neural stem cells induced by a natural flavonoid, baicalin. Chembiochem. 2011;12(3):449-456.
197. Woo KW, Kwon OW, Kim SY, et al. Phenolic derivatives from the rhizomes of Dioscorea nipponica and their anti-neuroinflammatory and neuroprotective activities. J Ethnopharmacol. 2014;155(2):1164-1170.
198. Guan S, Zhang X-L, Ge D, Liu T-Q, Ma X-H, Cui Z-F. Protocatechuic acid promotes the neuronal differentiation and facilitates survival of phenotypes differentiated from cultured neural stem and progenitor cells. Eur J Pharmacol. 2011;670(2):471-478.
199. Lin C-Y, Ni C-C, Yin M-C, Lii C-K. Flavonoids protect pancreatic beta-cells from cytokines mediated apoptosis through the activation of PI3-kinase pathway. Cytokine. 2012;59(1):65-71.
200. El Omri A, Han J, Yamada P, Kawada K, Abdrabbah MB, Isoda H. Rosmarinus officinalis polyphenols activate cholinergic activities in PC12 cells through phosphorylation of ERK1/2. J Ethnopharmacol. 2010;131(2):451-458.
201. Nishina A, Kimura H, Tsukagoshi H, et al. Neurite outgrowth of PC12 cells by 4′-O-β-d-glucopyranosyl-3′, 4-dimethoxychalcone from Brassica rapa L. 'hidabeni' was enhanced by pretreatment with p38MAPK inhibitor. Neurochem Res. 2013;38(11):2397-2407.
202. Zeni ALB, Zomkowski ADE, Maraschin M, Rodrigues ALS, Tasca CI. Involvement of PKA, CaMKII, PKC, MAPK/ERK and PI3K in the acute antidepressant-like effect of ferulic acid in the tail suspension test. Pharmacol Biochem Behav. 2012;103(2):181-186.
203. Maher P, Akaishi T, Abe K. Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc Natl Acad Sci U S A. 2006;103(44):16568-16573.
204. Mendonca LM, da Silva Machado C, Teixeira CCC, de Freitas LAP, Bianchi MdLP, Antunes LMG. Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells. Neurotoxicology. 2013;34:205-211.
205. Levites Y, Amit T, Mandel S, Youdim MB. Neuroprotection and neurorescue against Aβ toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J. 2003;17(8):952-954.
206. Levites Y, Amit T, Youdim MB, Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem. 2002;277(34):30574-30580.